Ken Fisher acquired 712 Thousand Haemonetics shares worth $48.4 Million. That's 0.02% of their equity portfolio (211th largest holding). The investor owns 1.51% of the outstanding Haemonetics stock. The first Haemonetics trade was made in Q1 2013. Since then Ken Fisher bought shares eighteen more times and sold shares on 26 occasions. The stake costed the investor $47.4 Million, netting the investor a gain of 2.1% so far.